Table of Contents
The U.S. Department of Health and Human Services released a report Aug. 13 alleging that hospitals and clinics nationwide billed nearly $120 million for gender-related treatments provided to minors since 2019, with the HHS Wolves in White Coats report citing conservative advocacy organization Do No Harm as the source of that figure.
What the HHS Wolves in White Coats Report Actually Alleges
According to HHS, more than 225 hospitals and health systems established pediatric gender programs nationwide. The report analyzes claims data from 2015 through 2025 and identifies approximately $50 million in insurance claims for puberty blockers billed using endocrine disorder diagnostic code E34.9, rather than a gender dysphoria diagnosis. HHS said the providers billed for the therapies to treat minors aged 9 to 17, and the report alleges these diagnostic coding practices resulted in payments from both private and government-sponsored health plans.
Who Contributed to This Report
The report includes contributors who have been publicly critical of gender-affirming care, according to reporting on the document. This authorship is a relevant consideration for readers evaluating the report’s framing and conclusions, since it was not produced as an independent or peer-reviewed audit.
The Financial Argument Within the HHS Wolves in White Coats Report
HHS said that as gender-related care for minors has grown, it has become a larger revenue source for hospitals, arguing this created financial incentives for more frequent billing. The report frames pediatric departments as historically lower-margin units within health systems and suggests gender-related treatment became, in the report’s characterization, a recurring revenue source.
Specific Hospitals Named in the Report
Some reporting on the document cites specific billing figures tied to individual hospitals, including Boston Children’s Hospital, though these figures originate from the report itself and the advocacy organization it cites, not from independently verified hospital financial records.
The Political Response to the HHS Wolves in White Coats Report
The report’s release prompted Vice President JD Vance to send a request to the Department of Justice for a criminal investigation into hospitals and healthcare providers over the alleged billing practices. HHS officials, including the current assistant secretary for health, stood alongside Vance at the announcement.
Why This Referral Matters
A vice presidential referral to the DOJ represents a significant escalation beyond the report’s publication alone, moving the underlying allegations from a policy document into a formal request for federal law enforcement review, though any resulting investigation and its findings would be separate from and independent of the HHS report’s own conclusions.
Why This HHS Wolves in White Coats Report Is Contested
Gender-affirming care for minors remains a medically and politically contested topic, with major U.S. medical associations, including the American Academy of Pediatrics and the American Medical Association, having historically supported individualized, guideline-based approaches to treating gender dysphoria in adolescents, while other clinicians, researchers, and some European health systems have raised concerns about the evidence base for certain interventions in minors. This report was commissioned by HHS under an administration that has taken an active policy position opposing gender-affirming care for minors, including a separate CMS rule ending Medicaid and CHIP funding for these treatments effective Oct. 13.
No Independent Hospital Response Identified
At the time of this report’s release, no statement from the named hospitals, national hospital associations, or major medical societies disputing the report’s specific billing allegations was identified in available coverage; readers should watch for such responses as this story develops further.
What This HHS Wolves in White Coats Report Means Going Forward
With Vance’s DOJ referral now pending, hospitals named or implicated in the report may face formal federal investigation into their billing and coding practices for pediatric gender-related care, a process that would need to independently substantiate the report’s claims before any legal consequences could follow. Given the report’s origin as an HHS-commissioned document with authors who have publicly opposed gender-affirming care, and its heavy reliance on figures from an advocacy organization rather than independent auditors, the report’s findings should be understood as one contested account within an active and unresolved federal and medical dispute rather than an adjudicated finding of fraud.
What to Watch Going Forward
As the DOJ considers Vance’s referral, observers should watch for whether federal investigators independently verify the report’s specific billing allegations, and for responses from the hospitals named, medical associations, and gender-affirming care providers who have not yet been quoted disputing the findings in available coverage. Given this report’s connection to broader federal policy changes, including the separate Medicaid and CHIP funding rule taking effect in October, the HHS Wolves in White Coats report is likely to remain a central and disputed reference point in the ongoing national debate over gender-affirming care for minors.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
